Nordic Everolimus (Certican) Trial in Heart and Lung Transplantation

Clinical trial NCT00377962 · COMPLETED

Trial details

NCT number: NCT00377962
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Disorder Related to Cardiac Transplantation

Start date: 2005-12-01
Primary completion: 2010-02-01
Enrollment: 282

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.